| Baptist Medical Center Creates New Web Page for Prostate Treatment ...
In an effort to educate men on their prostate cancer treatment options in Mississippi, Baptist created a new web page to explain the variety of treatments. (PRWEB) June 29, 2007 -- Baptist Cancer Services, a division of Baptist Medical Center in Jackson, Miss., has created a new web page to explain the different treatment options for prostate cancer. The new link is available on the cancer page of Baptist's website at www.mbhs.org then click the prostate cancer treatment link on the left side of the page. Through the years, Baptist Cancer Services, a division of Baptist Medical Center in Jackson, Miss., offers annual free prostate screenings every September and a variety of free educational seminars helping men understand their risk and treatment options. .
Prostate cancer treatment cuts hot flashes
ROCHESTER, Minn., June 4: A U.S. study finds use of low doses of an epileptic seizure medication can significantly reduce the occurrence of hot flashes in prostate cancer patients.The North Central Cancer Treatment Group researchers based at the Mayo Clinic found use of the drug gabapentin that's also used to treat nerve pain caused by shingles substantially reduces hot flashes in men undergoing anti-hormonal treatment, or androgen-deprivation therapy, for prostate cancer.The investigators found gabapentin cut the frequency and intensity of hot flashes up to 46 percent in men receiving androgen deprivation therapy."To my knowledge, this is the first non-hormonal treatment of hot flashes in men, where results from a placebo-controlled trial are positive enough to support that a non-hormonal medication can be used to help some of our patients," lead investigator Dr.
New Adjuvant Treatments For Breast Cancer Prove Cost-effective
Science Daily New adjuvant treatments for breast cancer are cost-effective at improving survival, according to two new studies. Published inthe journal CANCER, the two studies looked at the cost-effectiveness of different drugs for the management of adjuvant therapies for early breast cancer. .
|
